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Summary
We examined the mechanism by which PGE2 suppresses the expression of TNF-Æ in human macrophages and synovial fibroblasts.
Prostaglandin E2 increased, in a time and dose-dependent (EC50 75±15 ng/ml, mean±SD) fashion, the expression and synthesis of
Egr-1/Krox24 as judged by Northern blotting and electrophoretic mobility gel-shift analysis, respectively. In human macrophagic THP-1 cells,
rhIL-17 increased promoter activity by 7.6±0.35-fold over controls, an effect that was abrogated in a dose-dependent fashion by co-
incubations with PGE2 (IC50 25±4 ng/ml). An intact Egr-1/Krox-24 enhancer sequence in the TNF-Æ promoter region was essential for the
latter PGE2-dependent inhibitory effect as double base substitutions (GC fi TT) in the sequence curtailed promoter response to PGE2.
Overexpression of two dominant negative Egr-1/Krox-24 constructs in THP-1 cells considerably diminished the inhibitory effects of PGE2 on
rhIL-17-induced TNF-Æ mRNA expression. We conclude that PGE2 inhibits induced TNF-Æ expression in target cells through an
Egr-1/Krox-24 mediated signaling process.
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Prostaglandin E2 (PGE2) is a pleiotropic autacoid that
exerts both physiological and pharmacological actions in
essentially every tissue of the human organism.1 The PGE2
signal is transduced at the cell surface by specific cognate
receptors that are characterized by serpentine, seven-
membrane spanning domains and are coupled to GTP-
binding proteins at the inner membrane surface.2 In some
target cell types, PGE2 stimulates protein kinase C (PKC)
via phospholipase C/phosphoinositide hydrolysis/Ca+ + flux
and protein kinase A (PKA) via cAMP.3,4 The latter pro-
cesses can be activated within seconds to minutes and is
followed by increased transcription of immediate early
genes such as c-jun, jun B, and c-fos.5 These early gene
products are transcription factors that, along with CREB/
ATF, c/EBP and AP-2, modify the expression of PGE2
target genes and are often associated with mitogenic and
differentiation signals in many cell types.
Preliminary data from our lab suggests that a zinc-finger
transcription factor, the early growth response gene
Egr-1/Krox-24, may also be a target gene of PGE2 (see
below). Expression of Egr-1/Krox-24 is induced during
differentiation of myeloid cells, nerve, and bone and has
been shown to be essential and determinant for macro-
phage differentiation.6,7 It is a strong nuclear DNA-binding
protein that specifically recognizes the sequence
5¢ -GCG(T/G)GGGCG-3 ¢ and can trans-activate promoters
containing the appropriate cognate site.8 Promoters con-
taining active binding/transcription sites for Egr-1/Krox-24
include TNF-Æ9 and we investigated in this present study395whether PGE2 inhibition of TNF-a gene expression and
synthesis in human macrophages (or synovial fibroblasts)
was mediated by Egr-1/Krox-24 trans-repression of the
TNF-Æ promoter.Materials and methods
CELL CULTURE
Human peripheral blood mononuclear cells (HPBMCs)
were isolated from healthy donors by Ficoll-Hypaque
density centrifugation (Pharmacia Biotech, Baie D’Urfe´,
Que´) as previously described10 and the monocytes/
macrophages were allowed to adhere to plastic dishes
(Flow Laboratories, McLean, VA) in medium containing
RPMI 1640 (Life Technologies, Grand Island, NY), 10%
fetal calf serum, and penicillin/streptomycin (antibiotics).
THP-1 cells were cultured as suspensions in the same
medium as the macrophages while human synovial fibro-
blasts were isolated and cultured in DMEM (Life Tech-
nologies, Grand Island, NY), 10% fetal calf serum, and
11*Address correspondence to: John A. Di Battista, Unite´ de
recherche en arthrose, Centre de recherche L.C. Simard, CHUM
Campus Notre-Dame, Room Y-2603, 1560 rue Sherbrooke est,
Montre´al (Qc)., H2L 4M1.ISOLATION OF RNA AND NORTHERN BLOTTING
Total RNA was isolated from control and treated cells by
a one-step extraction procedure using the Trizol reagent
(Life Technologies, Grand Island, NY). Agarose-gel electro-
phoresis and northern blotting were performed on 5–10 ìg
of total RNA as previously described.11 The cDNA probes
for Egr-1, TNF-Æ, GAPDH were previously described8,10,11
and labeled by random priming with DIG-labeled dUTP
(Boehringer Mannheim Corp, Laval, Qc).
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Nuclear protein extracts (10–15 ìg) from control and
treated cells were added to binding reactions consisting of
100 000 cpm of 32P-labeled oligonucleotide probe (e.g.,
Egr-1 consensus, 5¢ -GGATCC AGC GGG GGC GAG CGG
GGG CGA-3¢ ) in 10 ìl of binding buffer [10 mM Tris-HCl,
pH 7.5, 50 mM NaCl, 0.5 mM DTT, 0.5 mM EDTA, 1 mM
MgCl2, 4% glycerol, and 2.5 ìg poly(dI-dC)]. Binding com-
plexes were resolved by nondenaturing polyacrylamide gel
electroporesis at 4°C through 6% gels in a Tris-borate
buffer system after which the gels were fixed, dried, and
prepared for autoradiography.12TRANSFECTION AND REPORTER ASSAYS
Expression plasmids for wt Egr-1/Krox24, two dominant
negative mutants ˜Egr-1/Krox24, ˜Egr-1/Krox24zf, vector
pGK promoter alone and pTNF-615-SVOCAT were trans-
fected into THP-1 monocytic cells (107/0.5 ml RPMI 1640
10% fetal calf serum, and antibiotics) by electroporation
(7 sec pulse 300 V, 960 ìF). TNF-Æ promoter activity was
assessed by measuring CAT protein by ELISA (Boehringer
Mannheim Corp, Laval, Qc) and the expression of Egr-1/
Krox24 constructs by Northern (mRNA) and Western
11,12Fig. 1. Time and dose-dependent induction of Egr-1/Krox24 mRNA expression by PGE2. Human synovial fibroblasts (1.5×106 cells) were
either (A) incubated with 2 ìg/ml of PGE2 for 0–16 h or (B) with increasing concentrations (0–20 ìg/ml) of PGE2 for 30 min. Cell monolayers
were rinsed with ice-cold PBS, total RNA was extracted and Northern analysis was performed with 8 ìg RNA/lane using a Egr-1/Krox24
cDNA probe as described in the Materials and methods section.(protein) analysis as previously described.Results
Prostaglandin E2 stimulated the expression of Egr-1/
Krox24 mRNA in a time and dose dependent fashion(Figs 1A and 1B) in synovial fibroblasts. Similar results
were obtained with human macrophages in primary culture
(data not shown). A rapid, cycloheximide-independent,
inductive phase was observed within minutes reaching a
zenith after 30 min and declining thereafter. A second
phase of increased mRNA was also evident at 4 h suggest-
ing autoregulation. The EC50 for PGE2 stimulation of
Egr-1/Krox24 was 75±15 ng/ml (mean±SD, N=4) and a
response was evident at 5–10 ng/ml. Increased Egr-1/
Krox24 protein synthesis, as judged by increased binding
to a consensus Egr-1/Krox24 32P-labeled oligonucleotide in
EMSA assays was observed after 1 h and remained stable
for up to 8 h and then declined to control values at 16 h
(data not shown).
Interleukin-17 (IL-17) induced TNF-Æ mRNA expression
and protein synthesis was blocked by PGE2 with an IC50 of
5 ng/ml in human macrophages. In THP-1 cells, IL-17
stimulated wt TNF-Æ promoter activity by 7.6±0.35-fold: the
increase was abrogated in a dose-dependent fashion by
PGE2 (IC50, 25±4 ng/ml, Fig. 2). Site directed mutagenesis
of the Egr-1 enhancer sequence in the TNF-Æ promoter at
positions −167 and −168 bp (GC to TT), resulted in a
marked dimunition of the inhibitory effect of PGE2 on TNF-Æ
increases in CAT activity (Fig. 2).
Over-expression, either stable or transient, of Egr-1/
Krox24 dominant negative mutants (e.g., ˜Egr-1/Krox24,
zinger finger removed; ˜Egr-1/Krox24zf construct express-
ing only the zinc finger) considerably diminished the inhibi-
tory effects of PGE2 on (IL-17) induced TNF-Æ mRNA
expression in THP-1 cells or synovial fibroblasts (data not
shown). In companion experiments, over-expression of
wt Egr-1/Krox24 mimicked the effects of PGE in terms2
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shown).Discussion
We demonstrate in this study that PGE2 inhibits the
expression of TNF-Æ through a mechanism involving the
suppression of the cytokine’s promoter activity via an Egr-1
sequence in the 5¢ flanking region of the TNF-Æ gene.
TNF-Æ production is regulated at several levels and indeed
transcriptional, post-transcriptional, and post translational
mechanisms have been described.13 At least 3 ŒB
enhancer sequences, a CRE-like sequence, and an Egr-1
sequence have been identifed in the proximal promoter
region of the TNF-Æ gene.14 No known TNF-Æ stimuli, with
the possible exception of IL-17,10 function through the ŒB
sites while TNF-Æ is believed to activate (autoregulate)
TNF-Æ promoter activity through the CRE-like site.15 Para-
doxically, cAMP-elevating agents suppress TNF-Æ expres-
sion and it is believed that this CRE-site may play an
important role.15 Phorbol esters (e.g., PMA) are powerful
stimulators of TNF-Æ production and the Egr-1 site behaves
as PMA inducible enhancer in this regard.9 However, the
latter PMA-dependent Egr-1 enhancer function depends on
the 3¢ CRE-like sequence which, if deleted, abrogates the
Egr-1 enhancer effect on the TNF-Æ promoter.9 Interest-
ingly PGE2 is a cAMP elevating agent1,4 and can presum-
ably regulate target gene expression through CRE sites
while at the same time, as shown in this present study,increase Egr-1 dramatically. Given this complicated
scenario, more studies are necessary before one can
speculate on the mechanism by which PGE2 reverses
IL-17 or PMA stimulation of TNF-Æ expression.
Far from being by-products of lipid metabolism, prosta-
glandins are important biological effectors with arguably the
most extensive set of target genes. In the context of
inflammatory and arthritic diseases, a growing body of
evidence suggests that PGE2 exerts many important anti-
catabolic and pro-anabolic activities. These latter studies
may provide a rationale for the untoward and deleterious
effects of long-term NSAID therapy.Fig. 2. Inhibition by PGE2 of IL-17 induced TNF-Æ promoter activity. Ten ìg of the wild-type or mutated pTNF615 SVOCAT plasmid were
transiently transfected into 107 THP-1 cells by electroporation. Cells were then incubated with vehicle, or 50 ng/ml of IL-17 in the presence
or absence of increasing concentrations (0–10 000 ng/ml) of PGE2. Control and treated cells were then lysed and total CAT protein was
measured by ELISA as described in the Materials and methods section.References
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